Advances in genetics: What are the benefits for patients?

Journal of Medical Genetics

Volumn 43, Issue 7, 2006, Pages 555-556

  Munnich, A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; IDEBENONE; MERCAPTAMINE; RAPAMYCIN;

CARDIOMYOPATHY; CLINICAL TRIAL; CYSTINOSIS; DRUG INDUSTRY; DRUG INHIBITION; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; GENETIC DISORDER; HUMAN; MEDICAL RESEARCH; MOLECULAR GENETICS; NOTE; PRIORITY JOURNAL; TUBEROUS SCLEROSIS;

CLONING, MOLECULAR; GENE THERAPY; GENETIC DISEASES, INBORN; GENETICS, MEDICAL; HUMANS;

EID: 33745899957     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2005.039966     Document Type: Note

References (22)

1. Refsum S. Heredopathia atactica polyneuritiformis phytanic-acid storage disease, Refsum's disease: a biochemically well-defined disease with a specific dietary treatment. Arch Neurol 1981;38:605-6.
2. Solis JO, Singh RH. Management of fatly acid oxidation disorders: a survey of current treatment strategies. J Am Diet Assoc 2002;102:1800-3.
3. Freeze HH. Disorders in protein glycosylation and potential therapy: tip of an iceberg? J Pediatr 1998;133:593-600.
4. Suormala T, Fowler B, Duran M, Burtscher A, Fuchshuber A, Tratzmuller R, Lenze MJ, Raab K, Baur B, Wick H, Baumgartner R. Five patients with a biotin-responsive detect in holocarboxylase formation: evaluation of responsiveness to biotin therapy in vivo and comparative biochemical studies in vitro. Pediatr Res 1997;41:666-73.
5. Walter JH, Wraith JE, White FJ, Bridge C, Till J. Strategies for the treatment of cystathionine beta-synthase deficiency: the experience of the Willink Biochemical Genetics Unit over the past 30 years. Eur J Pediatr 1998;157:S71-6.
6. Schuh S, Rosenblatt DS, Cooper BA, Schroeder ML, Bishop AJ, Seargeant LE, Haworth JC. Homocystinuria and megaloblastic anemia responsive to vitamin B12 therapy. An inborn error of metabolism due to a defect in cobalamin metabolism. N Engl J Med 1984;310:686-90.
7. Belal S, Hentati F, Ben Hamida C, Ben Hamida M. Friedreich's ataxia-vitamin E responsive type. The chromosome 8 locus. Clin Neurosci 1995;3:39-42.
8. Vergani L, Barile M, Angelini C, Burlina AB, Nijtmans L, Freda MP, Brizio C, Zerbetto E, Dabbeni-Sala F. Riboflavin therapy. Biochemical heterogeneity in two adult lipid storage myopathies. Brain 1999;122:2401-11.
9. Hoppel C. The role of carnitine in normal and altered fatty acid metabolism. Am J Kidney Dis 2003;41:S4-12.
10. Rötig A, Appelkvist EL, Geromel V, Chretien D, Kadhom N, Edery P, Lebideau M, Dallne G, Munnich A, Ernster L, Rustin P. Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 2000;356:391-5.
11. Schulze A, Bachert P, Schlemmer H, Harting I, Polster T, Salomons GS, Verhoeven NM, Jakobs C, Fowler B, Hoffmann GF, Mayatepek E. Lack of creatine in muscle and brain in an adult with GAMT deficiency. Ann Neurol 2003;53:248-51.
12. Coubes P, Roubertie A, Vayssiere N, Hemm S, Echenne B. Treatment of DYT1-generalised dystonia by stimulation of the internal globus pallidus. Lancet 2000;355:2220-1.
13. Pastores GM, Barnett NL. Current and emerging therapies for the lysosomal storage disorders. Expert Opin Emerg Drugs 2005;10:891-902.
14. Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP, the E/beta Thalassaemia Study Group. Fetal haemoglobin augmentation in E/beta thalassaemia: clinical and haematological outcome. Br J Haematol 2005;131:378-88.
15. Kleta R, Gahl WA. Pharmacological treatment of nephropathic cystinosis with cysteamine. Expert Opin Pharmacother 2004;5:2255-62.
16. Lindstedt S, Holme E, Lock EA, Hjalmarson O, Strandvik B. Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 1992;340:813-17.
17. Kwiatxowski DJ, Manning BD. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet 2005;14:R251-8.
18. Ben-Chetrit E, Bergmann S, Sood R. Mechanism of the anti-inflammatory effect of colchicine in rheumatic diseases: a possible new outlook through microarray analysis. Rheumatology (Oxford) 2006;45:274-82.
19. Djouadi F, Bonnefont JP, Thuillier L, Droin V, Khadom N, Munnich A, Bastin J. Correction of fatty acid oxidation in carnitine palmitoyl transferase 2-deficient cultured skin fibroblasts by bezafibrate. Pediatr Res 2003;54:446-51.
20. Munns CF, Rauch F, Travers R, Glorieux FH. Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome. J Bone Miner Res 2005;20:1235-43.
21. Rustin P, von Kleist-Retzow JC, Chantrel-Groussard K, Sidi D, Munnich A, Rötig A. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet 1999;354:477-9.
22. Wilschanski M, Yahav Y, Yaacov Y, Blau H, Bentur L, Rivlin J, Aviram M, Bdolah-Abram T, Bebok Z, Shushi L, Kerem B, Kerem E. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N Engl J Med 2003;349:1433-41.